                               SEQUENCE LISTING

<110> WISCONSIN ALUMNI RESEARCH FOUNDATION
 
<120> METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

<130> 032026-1358

<140> PCT/US2017/047823
<141> 2017-08-21

<150> 62/378,925
<151> 2016-08-24

<160> 19    

<170> PatentIn version 3.5

<210> 1
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Lys Trp Val Lys His Trp Val Lys Gly Gly Tyr Tyr Tyr Tyr His Asn 
1               5                   10                  15      


Leu Glu Thr Gln Glu Gly Gly Trp Asp Glu Pro Pro 
            20                  25              


<210> 2
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Leu Ile Thr Arg Leu Gln Ala Arg Cys Arg Gly Tyr Leu Val Arg Gln 
1               5                   10                  15      


Glu Phe Arg Ser 
            20  


<210> 3
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Ala Ile Thr Cys Ile Gln Ser Gln Trp Arg Gly Tyr Lys Gln Lys Lys 
1               5                   10                  15      


Ala Tyr Gln Asp 
            20  


<210> 4
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Glu Val Val Lys Ile Gln Ser Leu Ala Arg Met His Gln Ala Arg Lys 
1               5                   10                  15      


Arg Tyr Arg Asp 
            20  


<210> 5
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Asp Ile Ile Lys Ile Gln Ala Phe Ile Arg Ala Asn Lys Ala Arg Asp 
1               5                   10                  15      


Asp Tyr Lys Thr 
            20  


<210> 6
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 6
Leu Ala Asn Glu Gly Leu Ile Thr Arg Leu Gln Ala Arg Cys Arg Gly 
1               5                   10                  15      


Tyr Leu Val Arg Gln Glu Phe Arg Ser Arg Met Asn Phe Leu 
            20                  25                  30  


<210> 7
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 7
Lys Lys Gln Ile Pro Ala Ile Thr Cys Ile Gln Ser Gln Trp Arg Gly 
1               5                   10                  15      


Tyr Lys Gln Lys Lys Ala Tyr Gln Asp Arg Leu Ala Tyr Leu 
            20                  25                  30  


<210> 8
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 8
Arg Ser His Lys Asp Glu Val Val Lys Ile Gln Ser Leu Ala Arg Met 
1               5                   10                  15      


His Gln Ala Arg Lys Arg Tyr Arg Asp Arg Leu Gln Tyr Phe 
            20                  25                  30  


<210> 9
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 9
Arg Asp His Ile Asn Asp Ile Ile Lys Ile Gln Ala Phe Ile Arg Ala 
1               5                   10                  15      


Asn Lys Ala Arg Asp Asp Tyr Lys Thr Leu Ile Asn Ala Glu 
            20                  25                  30  


<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu 
1               5                   10  


<210> 11
<211> 36
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 11
gatggatccg gtgaaactta ccacagtgat cttgct                                 36


<210> 12
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      primer"

<400> 12
gataagcttc taatcctcag cattgatgag agtcttgta                              39


<210> 13
<211> 51
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 13
catctctggg gtgactgccc atataaccga gaacagctgt ggctggtcga c                51


<210> 14
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 14
ggaaagcucu ggcaauuuau u                                                 21


<210> 15
<211> 21
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 15
gaacguggcu uaugaguacu u                                                 21


<210> 16
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 16
aagttggagc actcttgg                                                     18


<210> 17
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 17
gcacattatc cctacctta                                                    19


<210> 18
<211> 25
<212> RNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      oligonucleotide"

<400> 18
ugacuccugg aagaauacuc cugua                                             25


<210> 19
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Val Arg Arg Leu Gln Arg Thr Leu Gln Phe Glu Arg Cys Arg Leu Ile 
1               5                   10                  15      


Ser Tyr Ala Gly 
            20  


